NEWS
Ebara Boshan Pumps expands China plant
which already includes the Flygt, Wedeco, Sanitaire and Leopold product brands. For further information, visit www.ittwww.com and www.itt.com
E
bara Boshan Pumps Co Ltd is planning a Yn32 million expansion of its factory in Boshan, China. The investment will add approximately 4600 sq m to the plant, reinforcing pump test facilities and extending the pump assembly shop. The expansion is scheduled for completion in summer 2011. The factory, which mainly manufactures feed pumps and cooling water pumps for thermal power and nuclear power plants, first opened in 2006. Ebara Boshan Pumps is a joint venture company between Japan’s Ebara Corp and China’s Shandong Boshan Pump Science and Technology Co.
For further information, visit www.ebara-boshanpump. com, www.ebara.co.jp and www.boshanpump.com.cn
ITT seals Godwin Pumps acquisition
I
TT Corp has completed the acquisition of Godwin Pumps, a specialist in the sale and rental of automatic self-priming portable pumps for the global industrial, construction, mining, municipal, oil and gas markets (see Pump Industry Analyst, June 2010). “Combining the Godwin team with our own creates a leading offering in dewatering pumps and services, and fits well with our strategy to build on our strong global positions in water and wastewater management,” said Gretchen McClain, president of the ITT Fluid and Motion Control group. “Adding the specialised products and skills of the world-class Godwin team to our broad Flygt and Grindex submersible pump portfolio and ITT global sales network means our customers will have access to one of the broadest dewatering capabilities on the market.” Godwin Pumps has a US rental fleet of more than 6000 pumps at 26 equipment rental facilities and a network of approximately 50 distributors worldwide. Godwin Pumps had 2009 revenues of about US$200 million, with full-year 2010 revenue projected to be about US$235 million. The newly acquired business will operate within ITT’s Water & Wastewater business, 16
Pump Industry Analyst
Pentair doubles test capacity at Kansas City pump plant
P
entair has doubled the large pump testing capacity of its Kansas City, Kansas, manufacturing plant, following a US$2.3 million investment. Construction has recently been completed on the Test Floor Expansion Project, which will provide additional deep water testing capability for large municipal, commercial and industrial products to meet growing customer demand. Pumps with the Fairbanks Morse, Layne/ Verti-Line and Aurora pump brands are manufactured in the Pentair Kansas City facility, which first opened its doors in 1953.
For further information, visit www.pentair.com
KSB extends India foundry
K
SB Group has increased the capacity of its steel foundry in Vambori, India. By adding two new natural gas-fired furnaces, KSB has increased steel castings output from 300 tons to 1200 tons per year. The Vambori foundry specialises in difficult to cast steels and stainless steels, for example duplex and chrome steels, or ASTM grades such as CF8M, CF3M or CN7M. The new environmentally friendly foundry has a flue gas collector and dust extraction systems to control air pollution and its own water treatment plant. Up to 80% of the sand used for moulds and cores is reclaimed. The foundry has three ovens: one for drying moulds, one for drying cores and another for scrap metal heating. KSB says that demand for high-quality steel castings within the global group is continuously increasing.
For further information, visit www.ksb.com
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843933 Web: www.pumpindustryanalyst.com Editor: Roisin Reidy E-mail:
[email protected] Production Support Manager: Lin Lucas E-mail:
[email protected] Publisher: Greg Valero E-mail:
[email protected] Subscription Information An annual subscription to Pump Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1120 for all European countries & Iran US$1256 for all countries except Europe and Japan ¥148 900 for Japan (Prices valid until 31 December 2010) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971/ Email:
[email protected], or via www.pumpindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Pump Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: permissions@ elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Printed by Mayfield Press (Oxford) LImited 02167
August 2010